Sign in

CIK 0000872912

  • Non-accelerated filer
  • Smaller reporting company

DELCATH SYSTEMS, INC.

Sign in to watch
Ticker
DCTH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061245881
Phone
+1 518-743-8892
Business address
566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
Former names
DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
  1. 4 Grant or award GM INTERVENTIONAL ONCOLOGY acquired 13,441 shares (grant or award)
  2. 4 Grant or award GEN'L COUNSEL, CCO & SECY acquired 20,161 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Chief Medical Officer bought 40,000 shares at $3.00 ($120,000)
  15. 4 Open-market buy Chief Executive Officer bought 34,000 shares at $2.94 ($99,960)
  16. 4 Open-market buy Director bought 100,000 shares at $2.40 ($240,410)
  17. 4 Open-market buy SVP of Finance, PFO and PAO bought 30,000 shares at $2.43 ($72,900)
  18. 4 Open-market buy Chief Medical Officer bought 60,000 shares at $2.48 ($148,800)
  19. 4 Open-market buy See Remarks bought 40,000 shares at $2.48 ($99,200)
  20. 4 Open-market buy Chief Operating Officer bought 14,505 shares at $3.44 ($49,897)

Page 4 of 30 · 595 filings